These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11795950)

  • 1. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
    Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
    Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate.
    Shaw TJ; Vanderhyden BC
    Gynecol Oncol; 2007 Apr; 105(1):122-31. PubMed ID: 17169414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonally regulated expression and alternative splicing of kit ligand may regulate kit-induced inhibition of meiosis in rat oocytes.
    Ismail RS; Dubé M; Vanderhyden BC
    Dev Biol; 1997 Apr; 184(2):333-42. PubMed ID: 9133439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory role of kit ligand-c-kit interaction and oocyte factors in steroidogenesis by rat granulosa cells.
    Miyoshi T; Otsuka F; Nakamura E; Inagaki K; Ogura-Ochi K; Tsukamoto N; Takeda M; Makino H
    Mol Cell Endocrinol; 2012 Jul; 358(1):18-26. PubMed ID: 22366471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.
    Scappini B; Onida F; Kantarjian HM; Dong L; Verstovsek S; Keating MJ; Beran M
    Clin Cancer Res; 2001 Dec; 7(12):3884-93. PubMed ID: 11751479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ligand of the c-kit receptor promotes oocyte growth.
    Packer AI; Hsu YC; Besmer P; Bachvarova RF
    Dev Biol; 1994 Jan; 161(1):194-205. PubMed ID: 7507447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta regulates Kit ligand expression in rat ovarian surface epithelial cells.
    Ismail RS; Cada M; Vanderhyden BC
    Oncogene; 1999 Aug; 18(33):4734-41. PubMed ID: 10467421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Kit ligand/c-Kit receptor system in goat ovaries: gene expression and protein localization.
    Silva JR; van den Hurk R; van Tol HT; Roelen BA; Figueiredo JR
    Zygote; 2006 Nov; 14(4):317-28. PubMed ID: 17266790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin.
    Ricotti E; Bertorello N; Vai S; Pagani A; Cordero Di Montezemolo L; Madon E; Basso G
    Haematologica; 1999 Oct; 84(10):879-86. PubMed ID: 10509034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
    Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G
    Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.
    Attoub S; Rivat C; Rodrigues S; Van Bocxlaer S; Bedin M; Bruyneel E; Louvet C; Kornprobst M; André T; Mareel M; Mester J; Gespach C
    Cancer Res; 2002 Sep; 62(17):4879-83. PubMed ID: 12208734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression pattern of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia.
    Manova K; Huang EJ; Angeles M; De Leon V; Sanchez S; Pronovost SM; Besmer P; Bachvarova RF
    Dev Biol; 1993 May; 157(1):85-99. PubMed ID: 7683286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of tyrosine kinase inhibitor Imatinib mesylate on proliferation, differentiation and apoptosis of Kasumi-1 leukemia cell line].
    Wang LH; Rao Q; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):449-52. PubMed ID: 16383232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell factor/c-Kit interactions regulate human islet-epithelial cluster proliferation and differentiation.
    Li J; Goodyer CG; Fellows F; Wang R
    Int J Biochem Cell Biol; 2006; 38(5-6):961-72. PubMed ID: 16213778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture.
    Carlsson IB; Laitinen MP; Scott JE; Louhio H; Velentzis L; Tuuri T; Aaltonen J; Ritvos O; Winston RM; Hovatta O
    Reproduction; 2006 Apr; 131(4):641-9. PubMed ID: 16595715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal regulation of the ligand for c-kit in the rat ovary and its effects on spontaneous oocyte meiotic maturation.
    Ismail RS; Okawara Y; Fryer JN; Vanderhyden BC
    Mol Reprod Dev; 1996 Apr; 43(4):458-69. PubMed ID: 9052937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
    Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
    Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
    Warrenfeltz SW; Lott SA; Palmer TM; Gray JC; Puett D
    Mol Cancer Res; 2008 Nov; 6(11):1775-85. PubMed ID: 19010824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
    Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.